A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
| Image |  |
|---|---|
| Description | scientific article published on 28 September 2019 |
| Author/s |
author: Philip J Mease Paul Emery Philip Helliwell |
| Publication date | September 28, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |